Welcome Letter from Co-Chairpersons

It is our honor and pleasure to invite you to participate in the 19th MIXiii-BIOMED Conference and Exhibition, to be held May 12-14, 2020 in Tel Aviv, Israel.


Explore MIXiii BIOMED 2020 Conference Tracks

Featuring 9 tracks of programming, the MIXiii BIOMED 2020 Conference invites attendees to explore what’s next in the worlds of Biotechnology and Life Sciences.

Previous Events

MIXiii – Biomed 2019 Conference and Exhibition

18th National Life Sciences & Technology Week

May 15 – 17, 2019 | David InterContinental Tel Aviv, Israel

MIXiii – Biomed 2018 Conference and Exhibition

17th National Life Sciences & Technology Week

May 15 – 17, 2018 | David InterContinental Tel Aviv, Israel

MIXiii – Biomed 2017 Conference and Exhibition

May 24-26, 2017 David InterContinental Tel Aviv, Israel

16th National Life Science & Technology Week



Plenary Speakers

Robert Cohen
VP of Global R&D, Chief Technology Officer, Stryker Joint Replacement


Amy Schulman
Managing Partner, Polaris Partners


Prof. Robert Langer
Institute Professor at MIT, MIT Department of Chemical Engineering


Andrew “Cal” Callaway
Managing Director, U.S. Healthcare Investment Banking, Royal Bank of Canada (RBC)


Prof. Yitshak Kreiss, MD
Director General, Sheba Medical Center


Aharon Aharon
CEO, Israel Innovation Authority (IIA)


Eric H. Rubin MD
Senior VP, Global Clinical Oncology, Merck & Co 


Jeremy M. Levin MD
CEO and Chairman, Ovid Therapeutics

Tracks & Track Chairs

Targeted Cancer Treatment; Cure? Maintenance? – Has Medicine Reached these Points?
Chair: Prof. David Sidransky, MD,
Johns Hopkins School of Medicine; Co-Founder & General Partner, Israel Biotech Fund

Decoding the Brain Enigma: Parkinson, Alzheimer’s, ALS, Mental Disorders
Co-Chairs: Barry Greene
President, Alnylam Pharmaceuticals
Dekel Taliaz, PhD
Co-Founder and CEO, Taliaz

AI Technology Redefining the Future of Biopharma, Care Delivery, and Holistic Medicine
Co-Chairs: Iris Grossman, PhD
Chief Scientific Officer, Camp4 Therapeutics
Tamara Mansfeld
Global Innovation Lead, Digital Innovation Lab, Pfizer 

Next Generation BioTherapeutics – Gene Editing, RNAi, Oligos, Cell and Gene Therapies and others
Co-Chairs: Yaron Carmi, PhD
Assistant Professor, Sackler School of Medicine, Tel Aviv University
Jonathan Solomon
CEO, BiomX

Bright Spots Illuminating the Future of Medical Devices
Co-chairs: Irit Yaniv, MD
Managing Partner, Accelmed Ventures Fund
James Eadie, MD
Partner, Santé Ventures

Exact and Biological Science Diagnostics – Sensors, Genomics, AI, Imaging, and others
Co-Chairs: Prof. Varda Shalev, MD, MPA
Head, KSM Kahn – Sagol – Maccabi Research & Innovation Institute
Yair Schindel, MD
Managing Partner & Co-Founder, aMoon Fund

Robotics Role in Future Healthcare Systems
Chair: Ori Hadomi
VP New Business Development & Partnerships, Medtronic

Aging Science and Technology – From Single Cell to Population at Large
Co-Chairs: Anat Naschitz
Managing Director, OrbiMed Advisors
Yael Benvenisti, PhD
CEO, Mediterranean Towers Ventures

Bio-convergence – Biologically Inspired Engineering Reshaping Future Medicine

Invited Speakers (Preliminary List)

Federico Goodsaid, PhD
Ex-FDA & Senior VP Regulatory Affairs, Ariana Pharma

Dimitris Agrafiotis, PhD
Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)

Rosana Kapeller-Libermann, PhD
EIR, Google Ventures

Daphna Laifenfeld, PhD
Chief Strategy Officer, Ibex Medical Analytics

Michal Ozery-Flato, PhD
Machine Learning Researcher, IBM Research

Eric de La Fortelle, PhD
Venture Partner, Seventure

Pierre Belichard
CEO, Enterome

Jeremy M. Levin MD
CEO and Chairman, Ovid Therapeutics

Dimitrios Arkilo, MD
Sr. Medical Director, Global Clinical Lead. Takeda Pharmaceutical Co

Prof. Amir Lerman, MD
Cardiovascular Diseases and Internal Medicine, Mayo Clinic

Prof. Tamar Flash, PhD
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science

Wenbo Liu
Sinovation (Beijing) Medical Technology Co., LTD

Allitia DiBernardo, MD
Global Medical Affairs Lead, Neurosciences, The Janssen Pharmaceutical Companies of Johnson & Johnson

Prof. Peter A. Noseworthy, MD
Department of Cardiovascular Medicine
Mayo Clinic

Miro Venturi, PhD
Global Head – Diagnostics Biomarkers
F. Hoffmann-La Roche Ltd.

Barry Greene
President, Alnylam Pharmaceuticals

Tom Sudow
Director Business Development, Cleveland Clinic Innovations

MIXiii Biomed 2020 Sponsors

The conference serves as a meeting point for local and multinational companies, venture capitalists, private equity investors, corporate and institutional investors, technology transfer experts, licensing executives, business development executives, university, government and corporate research scientists and government representatives.

Diamond Sponsor

Gold Sponsor

SILVER Sponsor

Media Partner